Presenter: Andrea Califano, Dr., Clyde and Helen Wu Professor of Chemical Systems Biology, Columbia University Medical Center; Founding Chair, Department of Systems Biology; Director, JP Sulzberger Columbia Genome Center; Associate Director, Herbert Irving Comprehensive Cancer Center
Title: “Systematic Elucidation and Pharmacological Targeting of Non-Oncogene Dependencies in Human Malignancies: A New Take on Precision Oncology”
Brief Bio: Andrea Califano is the Clyde and Helen Wu Professor of Chemical Systems Biology at Columbia University Medical Center, the Founding Chair of the Department of Systems Biology, Director of the JP Sulzberger Columbia Genome Center, and Associate Director of the Herbert Irving Comprehensive Cancer Center. He is originally trained as a physicist and has applied physics-based approaches, including extensive use of information theory principles, to the reverse engineering and interrogation of gene regulatory networks to systematically and efficiently identify key tumor checkpoint modules, whose aberrant activity is necessary for tumor viability. This has resulted in several clinical trials, including a very innovative N of 1 study for precision cancer medicine. Dr. Califano has received several awards and recognitions, including the NCI Outstanding Investigator Award, fellow of the AAAS, and of the NY Academy of Medicine and Academy of Science. He is also the Co-founder of DarwinHealth Inc.
3:00 to 4:00 this afternoon
The Jackson Laboratory for Genomic Medicine Auditorium
For more information, contact: Devin Davis at devin.davis@jax.org